Entrada Therapeutics Inc. (TRDA)
NASDAQ · Healthcare
Entrada Therapeutics Inc. Income Statement 2023–2025
| Dec 2025 | Dec 2024 | Dec 2023 | |
|---|---|---|---|
| Revenues | |||
| Revenue | 25.4M | 210.8M | 129.0M |
| Gross Profit | — | — | — |
| Profitability | |||
| Operating Income | -157.9M | 47.0M | -3.2M |
| EBITDA | — | — | — |
| Net Income | -143.8M | 65.6M | -6.7M |
| Per Share Data | |||
| EPS (diluted) | $-3.47 | $1.68 | $-0.20 |
| Shares Outstanding (dil.) | 41M | 39M | 33M |
Entrada Therapeutics Inc. Income Statement — FAQ
Entrada Therapeutics Inc. (TRDA) income statement over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see TRDA's income statement history?
The chart and table above show Entrada Therapeutics Inc.'s income statement by year and by quarter, including the growth rate.